Figure 1: Guidelines for primary cytology# screening in South Africa

Slides:



Advertisements
Similar presentations
Clinical Use of HPV DNA Testing Thomas C. Wright, Jr. College of Physicians and Surgeons of Columbia University.
Advertisements

MANAGEMENT OF THE ABNORMAL PAP SMEAR
Treatment Options for CIN Cervical Cancer screening is designed to detect CIN If CIN is present treatment should theoretically avoid subsequent cancer.
ASHLYN SAVAGE, MD, MSCR ASSOCIATE PROFESSOR OBSTETRICS AND GYNECOLOGY MEDICAL UNIVERSITY OF SOUTH CAROLINA Managing Abnormal Pap Smears: Incorporating.
COLPOSCOPY RANDOM CERVICAL BIOPSIES ENDOCERVICAL CURETTAGE S.C.P.M.G.-Fontana.
HPV Sample Taker Training South West Regional Cytology Training Centre Southmead Hospital Bristol.
ACCP Evidence base: Implications for policy and practice R. Sankaranarayanan MD Head, Screening Group World Health Organization (WHO) International Agency.
Screening for Cervical Cancer
Management of Women with CIN 1 or LSIL
Benign and premalignant disease of the cervix
Interim Guidance for the Use of Human Papillomavirus DNA Testing as an Adjunct to Cervical Cytology for Screening Obstetrics and Gynecology, Volume 103,
COLPOSCOPY Cervical Screening QARC Training School October 2012.
CERVICAL SCREENING WITH LUVIVA MACHINE FOR EARLY DETECTION OF CERVICAL DYSPLASIA: EXPERIENCE FROM EKITI STATE, NIGERIA Sunday O. Omoya, Abimbola M. Obimakinde.
Review of the Guidelines for Cervical Screening in New Zealand Presentation for smear-takers September 2008.
Screening for Cervical Cancer Max Brinsmead MB BS PhD May 2015.
Abnormal Pap in Pregnancy Alexander Burnett, MD Division Gyn Oncology, UAMS April, 2006.
SoftPAP® A Novel Collection Device for Cervical Cytology.
In the Name of God. Screening of Cervical Cancer Pap smear and colposcopy F.Behnamfar Gynecology Oncology Fellowship Associate Professor Isfahan University.
1 Cervical Screening Programme, England, : Graphs.
Cervical Intraepithelial Neoplasm
PRINCess Trial Prediction of Regression in CIN2. Coordinating centre in Christchurch Mainly NZ but Sydney and Melbourne just completing their approval.
Premalignant lesions of the cervix. Applied anatomy.
NHS Cervical Screening Programme, England, : Graphs.
HPV testing as a Primary screening tool in England Dr Karin Denton.
Provisional MUO Audit Tania Tillett Medical Oncologist RUH.
Cervical Cancer: Experiences from a Cohort of HIV-infected Women Pascoe M, Magure T, Mudhokwani P et al Abstract: MOAB0202.
Morphologic Pap Test Findings in HPV Negative Women Age 30 Years and Older: What Information Will Be Lost with HPV Only Primary Screening? Brooke Henninger,
1 Cervical Cancer Screening Updates Dr. GORDON JOHNSON.
Cervical cancer screening and treatment among HIV+ women in Cambodia: feasible and high yielding M.-E. Raguenaud 1, P. Isaakidis 1, S.A. Khim 1, C. Ping.
Understanding Test Results
Public Health England leads the NHS Screening Programmes
Fig. 1. Framework of developing a guideline for cervical cancer screening. ① Benefits of pap test screening, ② harms of pap test screening, ③ accuracy.
Ontario Colposcopy Clinical Guidance 2016
Cancer prevention and early detection
Performance of mRNA- and DNA-based high-risk human papillomavirus assays in detection of high-grade cervical lesions ELINA VIRTANEN1, ILKKA KALLIALA2,3,
NEW SCREENING PROTOCOL WITH DUAL-STAINED CYTOLOGY TRIAGE
Trreatment of Preinvasive Lesions
Colposcopic Biopsy Results of HPV 16 and 18 patients in Bartın
NHS Cervical Screening Programme Introducing HPV Triage
INTRODUCTION: CERVICAL CANCER SCREENING
Cytology Codes & management Colposcopy- Management of cervical lesions
S S S - Figure 2: Guidelines for primary HPV screening in South Africa
Cervical Cancer in California
Cervical Cancer Colposcopy & Treatment
From: Inefficiencies and High-Value Improvements in U. S
Efficacy of random cervical biopsy and routine endocervical curettage in subjects with normal colposcopy.
Copyright © 2015 by the American Osteopathic Association.
Dr N Shailaja Dr Pradeep
Ontario Colposcopy Clinical Guidance 2016
Pap smear interpretation
Colposcopy triage. Satisfactory colposcopy is defined as complete visualization of the squamocolumnar epithelium, which comprises the cervical region most.
HPV DNA SCREENING, FROM CO-TESTING
Retest in 12mo with HPV testing
Hoa Nguyen Lam, Huyen Suong Ho Thi et al.
NHS Cervical Screening Programme, England : Graphs
Markers of human papillomavirus infection and their correlation with cervical dysplasia in human immunodeficiency virus-positive women  E. Riva, D. Serraino,
Updates on Pap Smear Guidelines 2014
Nat. Rev. Clin. Oncol. doi: /nrclinonc
کنترل کيفی در سيتولوژی سرويکوواژينال
Public Health England leads the NHS Screening Programmes
Primary HPV test screening
What is a Pap smear? A Pap smear (also known as the Pap test) is a medical procedure in which a sample of cells from a woman's cervix (the end of the uterus that.
Cervical excisional treatment of young women: A population-based study
SH-sheikhhasani Gyn-oncologist
Volume 153, Issue 1, Pages (April 2019)
Modern cervical cancer screening
Fig. 3. The examinations consumed by the three cervical screening strategies to detect CIN2+/CIN3+. (A) The cases of CIN2+ detected by three current cervical.
Fig. 2. Three cervical screening strategies to detect CIN2+/CIN3+
Fig. 1. Flowchart of inclusion and exclusion criteria of the study population.ASC-US, atypical squamous cells of undetermined significance; CIN, cervical.
Presentation transcript:

Figure 1: Guidelines for primary cytology# screening in South Africa Cervical cytology Negative for intra-epithelial lesions or malignancy ASCUS or LSIL HGSIL+ Low risk Medium risk High risk S Screen Triage* + Treat† - S Follow S Follow # To be phased out over time * High resource setting: cyto-staining; HPV test, repeat cytology * Low resource setting: VILI / VIA, repeat cytology † Treatment in high resource settings is usually done after colposcopy ± biopsy confirmation † In low resource settings treat all patients at first recall visit